ESR1 and breast cancer: A prospective cohort study including 514 Danish women with breast cancer and subtype classification of tumours by ER-, PR-, HER2, and Ki67 found that the BC subtype had no significant prognostic impact on the 20-year locoregional recurrence for both younger patients aged ≤45 years and older patients [240].